What was confirmed
HLA-B27 returned positive. MRI of the pelvis confirmed mild chronic sacroiliitis with shallow erosions and signs of active inflammation, matching the radiographic pattern. The working diagnosis became axial spondyloarthritis.
The morning facial puffiness — the original reason for referral — was not dismissed. A targeted workup for IgA nephropathy was performed, a known association with axial SpA. It returned no convincing evidence. The puffiness remained unexplained, but the rheumatologic origin of the back finding was now established beyond doubt.
What she remembered later
The initial history was thorough. She had honestly denied a family history of rheumatologic disease, prior eye inflammation, bowel symptoms, and other systemic features. The history was negative as taken.
After the diagnosis, things changed.
She asked her parents — and a strong family history of HLA-B27-associated disease emerged across multiple relatives. She herself recalled several earlier episodes that fit an enteritis pattern, episodes she had completely forgotten on the first visit. There may have been an episode of uveitis or scleritis several years earlier, treated topically as “inflammation” without documentation; this could not be confirmed or excluded retrospectively.
The lesson is not that the first interview was inadequate. It was thorough. The lesson is that patients do not link distant, separate episodes to their current concern until a diagnosis gives them a reason to.
A negative review of systems before a diagnosis is not the same as a negative review of systems after one. Returning to the history after a positive test is part of the diagnostic process, not a correction of it.
What MRI did not see
The MRI report confirmed the sacroiliac findings but contained no mention of the lumbosacral transitional anatomy or the pseudoarticulation. Only after a direct request to re-read the study was the Bertolotti-type variant added to the report.
On follow-up imaging one year later, the same omission occurred. The Bertolotti anatomy was again missed, and again added only after a targeted question to the radiologist.
In this case, the structured radiographic reading was more complete and more accurate than a sound but less structured MRI reading. Modality sensitivity is not the same as reading completeness. A more sensitive technique does not protect against a structured blind spot.
One year later
On treatment, the patient achieved full clinical remission with no symptoms. Follow-up radiographs showed no radiographic progression. Follow-up MRI showed no active sacroiliitis — only post-inflammatory change without progression. The early window was caught and used.
A note on the radiation
Some patients — and some clinicians — hesitate before plain films, worried about radiation. The numbers here, drawn out fully, do not support that hesitation.
The radiation side of the ledger. This eight-projection lumbosacral and SI series delivers approximately 4 mSv of effective dose — roughly 15 months of natural background radiation, or less than half a single abdominal CT. Using the ICRP linear-no-threshold model, this corresponds to an additional lifetime cancer risk of about 0.02% — roughly 1 in 4,600 — on top of a baseline general-population lifetime cancer risk of approximately 40%.
The untreated-disease side of the ledger. Skipping or delaying imaging is not a neutral act. Axial spondyloarthritis has its own well-documented harms when left undiagnosed and untreated:
- Diagnostic delay. Pooled global data show a mean delay of 6.7–7.4 years from symptom onset to diagnosis. Younger age at onset and female sex are associated with even longer delays.
- Cardiovascular risk. Patients with ankylosing spondylitis have a 60% higher risk of myocardial infarction — OR 1.60 — and a 50% higher risk of stroke — OR 1.50 — and a measurable increase in cardiovascular mortality — OR ~1.36.
- All-cause mortality. Standardised mortality ratio in radiographic axial SpA ranges 1.46–1.66 versus age- and sex-matched controls.
- Malignancy. Pooled data show a 14–16% higher overall cancer risk — RR 1.14–1.16 — with site-specific elevations for multiple myeloma — RR 1.74–1.92 — non-Hodgkin lymphoma — RR 1.32–1.42 — leukaemia — RR 1.52 — and several solid tumours; risks attributable in large part to the chronic inflammatory state itself.
- Structural and functional loss. Across years of unrecognised disease, erosions deepen, syndesmophytes form, ankylosis advances, and the reversibility window closes.
The arithmetic, fully drawn. The choice is not “radiation versus zero.” It is 0.02% theoretical added cancer risk from this single imaging series versus a measurable, multi-system, accumulating risk of cardiovascular events, mortality, additional cancer, and structural damage from leaving axial spondyloarthritis undiagnosed for the average 7 years it currently takes to be recognised.
In this patient, the films caught a classification-grade structural sacroiliitis early enough that one year of treatment produced full clinical remission, no radiographic progression, and no active inflammation on follow-up MRI.
Imaging that ends a 7-year diagnostic delay is not a radiation expense. It is a risk reduction.
What this case teaches
A subtle exam finding in a patient who had not come for back pain led to plain films, a structured reading caught a mild but classification-grade structural sacroiliitis, and an early-stage diagnosis was made before erosive damage advanced. A history that read as negative on first taking was not falsely negative — it was incomplete in a way that only the diagnosis itself could complete. And a more sensitive imaging modality, read without the same discipline, missed something the radiograph caught — twice.